CX3CR1 and systemic sclerosis: SSc patients were observed to have rising serum levels of sFKN and its receptor CX3CR1 T cells and peripheral macrophages/monocytes, which pathologically enrolls monocytes into the skin of patients with SSc, arbitrating the institution and propagation of skin sclerosis.